The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
This report focuses on the human gene RPL18A, encoding the cytosolic large-subunit ribosomal protein eL20 (also referred to in the literature as 60S ribosomal protein L18a). The retrieved literature explicitly uses the name eL20 (RPL18a/RPL18A) for a 60S large ribosomal subunit component, and an orthology study in C. elegans independently identifies its ortholog (rpl-20) as the ortholog of mammalian RPL18a/eL20 and as a 60S component, supporting the correctness of the target identity (UniProt Q02543 context). (kim2025ribosomalproteinmutation pages 1-2)
RPL18A/eL20 is a ribosomal protein of the cytosolic 60S large ribosomal subunit. Ribosomal proteins stabilize rRNA structure, contribute to assembly, and support translation by forming part of the ribosome’s structural framework. Direct RPL18A-specific structural placement within the 60S subunit was not retrieved as an explicit cryo-EM/structural annotation in the current corpus; however, its classification as a 60S component is explicit in orthology/genetics work and ribosome-focused reviews. (kim2025ribosomalproteinmutation pages 1-2)
Eukaryotic ribosome assembly is a multi-compartment process that begins in the nucleolus, continues in the nucleoplasm, and is completed after export to the cytoplasm for final maturation. This provides the expected cellular itinerary for all cytosolic ribosomal proteins (including RPL18A) during assembly, even when a specific RPL18A localization experiment is not available. (lindahl2024ribosomestructuralchanges pages 1-2)
Perturbation of ribosomal proteins can trigger “ribosomal stress” (also called nucleolar stress), often converging on p53 pathway activation and cell-cycle phenotypes. In a systematic study of ribosomal protein (RP) deficiencies, 60S RP deficiency was reported to exert stronger growth-inhibitory effects than 40S RP deficiency and to act through p53 signaling; the authors observed significant p53 protein increases for a subset of RPs and enrichment for RPs entering the biogenesis pathway in the nucleus among those affecting cell-cycle/p53 programs. (luan2022deficiencyofribosomal pages 1-2, luan2022deficiencyofribosomal pages 10-11)
A review of ribosomal proteins in viral translation summarizes experimental evidence that eL20 (RPL18A) can interact with hepatitis C virus (HCV) IRES RNA and that adding eL20 protein to in vitro translation extracts moderately stimulated HCV IRES activity. This supports a capacity for RPL18A/eL20 to contribute to specialized modes of translation initiation involving structured RNAs, beyond a purely passive structural role. (miller2021fatalattractionthe pages 8-9)
A genetics and ribosome profiling study in C. elegans identifies RPL-20 as the ortholog of mammalian RPL18a/eL20 and reports that an amino-acid substitution in this protein is associated with reduced biogenesis of the 60S subunit, leading to reduced 80S ribosomes. The same paper reports that a deletion allele removing the coding region is homozygous early larval lethal, supporting an essential role for the eL20 family protein in organismal viability consistent with fundamental ribosome function. Although this evidence is from an ortholog, it provides strong functional inference for human RPL18A’s essentiality for 60S biogenesis/steady-state ribosome abundance. (kim2025ribosomalproteinmutation pages 1-2)
Direct experimental localization of human RPL18A (e.g., immunofluorescence showing nucleolar accumulation) was not captured in the retrieved corpus. However, combining (i) its identity as a 60S ribosomal protein (kim2025ribosomalproteinmutation pages 1-2) and (ii) the general eukaryotic assembly route nucleolus→nucleoplasm→cytoplasm (lindahl2024ribosomestructuralchanges pages 1-2), the best-supported model is:
- Transient nuclear/nucleolar localization during ribosome biogenesis, followed by
- Predominantly cytoplasmic localization as part of mature 60S/80S ribosomes engaged in translation. (lindahl2024ribosomestructuralchanges pages 1-2, kim2025ribosomalproteinmutation pages 1-2)
A 2023 Cell study used an integrated chemical-proteomics and functional-genomics framework to map anticancer drug targets and ROS-sensitive protein sites and reported that C22 in RPL18A was among sites for ROS-controlled translation identified in their integrated analysis. This is a notable recent advance because it suggests a plausible mechanism for post-translational, redox-linked modulation of translation machinery involving RPL18A at a specific cysteine residue, even though the mechanistic consequences for RPL18A itself are not quantified in the extracted text. (zhang2023systematicidentificationof pages 18-19, zhang2023systematicidentificationof pages 1-3, zhang2023systematicidentificationof pages 11-13)
A 2023 review emphasizes that ribosomal heterogeneity exists and that “specialized ribosomes” may arise from altered ribosomal protein composition, rRNA/protein modifications, or associated factors, potentially changing affinity for subsets of mRNAs and affecting translation initiation/elongation and cotranslational folding. This provides an interpretive framework in which proteins like RPL18A could contribute to transcript-selective translation through variation in abundance or modifications. (miller2023specializedribosomesin pages 1-3)
A 2024 perspective similarly reviews evidence that ribosomes may differ in rRNA/protein content and that assembly begins in the nucleolus and proceeds through nucleoplasm to cytoplasm. This supports the modern view of ribosomes as potentially regulatory entities rather than uniformly invariant machines. (lindahl2024ribosomestructuralchanges pages 1-2)
Direct, RPL18A-specific clinical applications (e.g., a validated diagnostic biomarker or therapeutic target) were not retrieved in the current document set. The strongest application-adjacent contexts supported by retrieved evidence are:
Cancer drug-response mechanistic mapping: the 2023 Cell integrated proteogenomic approach identified RPL18A C22 among ROS-controlled translation sites in the context of anticancer drug target discovery and chemoresistance-related mechanisms, linking RPL18A to clinically relevant translational stress/ROS biology. (zhang2023systematicidentificationof pages 18-19, zhang2023systematicidentificationof pages 1-3, zhang2023systematicidentificationof pages 11-13)
Virology translation assays: experimental work summarized in a review indicates that purified eL20/RPL18A can interact with the HCV IRES and stimulate IRES-driven translation in vitro, making RPL18A relevant in mechanistic translation assays used in viral biology. (miller2021fatalattractionthe pages 8-9)
More general “real-world” relevance of ribosomal proteins (not RPL18A-specific) includes their roles in nucleolar stress, p53 pathway signaling, and disease processes (e.g., ribosomopathies), but these were not tied to RPL18A specifically in the retrieved 2023–2024 reviews. (hong2024researchprogressof pages 1-2)
The currently retrievable quantitative/statistical evidence is mostly contextual (ribosomal-protein class effects) rather than RPL18A-specific perturbation in human cells.
and other large-scale statistical signals noted in the extracted text. (luan2022deficiencyofribosomal pages 10-11)
The 2023 Cell study provides residue-level specificity (RPL18A C22) for a ROS-controlled translation site but the extracted text does not provide a numerical effect size specifically for RPL18A. (zhang2023systematicidentificationof pages 18-19)
A structured cross-study summary is provided below.
| Year | Reference (first author, journal) | Publication date | URL/DOI | System (human cell lines/organism) | What was measured/approach | Key finding about RPL18A/eL20 | Quantitative/statistical detail if present in extracted text | Relevance to functional annotation (translation/biogenesis/localization/disease) |
|---|---|---|---|---|---|---|---|---|
| 2021 | Miller, WIREs RNA | Jul 2021 | https://doi.org/10.1002/wrna.1613 | HCV IRES in in vitro translation assays; host ribosome context not further specified in snippet | Review summarizing prior experimental work on viral translation; cites in vitro translation assays | eL20/RPL18A was reported to interact with HCV IRES RNA, and adding eL20 protein to in vitro translation extracts moderately stimulated HCV IRES activity (miller2021fatalattractionthe pages 8-9, miller2021fatalattractionthe pages 9-11) | “moderately stimulated” HCV IRES activity; no numerical value in snippet (miller2021fatalattractionthe pages 8-9) | Direct evidence for a translation-related role of eL20/RPL18A beyond generic structural annotation; supports RNA interaction capability in the 60S context (miller2021fatalattractionthe pages 8-9, miller2021fatalattractionthe pages 9-11) |
| 2022 | Luan, Nucleic Acids Research | 2022 (month not visible in snippet) | https://doi.org/10.1093/nar/gkac053 | Human A549, U2OS, Neuro-2a, HUVECs mentioned in study methods; genome-wide RP knockdown framework | Ribo-seq/RNA-seq after knockdown of 75 human ribosomal proteins; CRISPR-Cas9 comparison; polysome profiling | Although RPL18A is not singled out in the extracted text, the study shows that deficiency of 60S ribosomal proteins causes stronger growth inhibition than 40S RP deficiency through p53 signaling, and that RPs entering ribosome biogenesis in the nucleus are enriched among those affecting cell-cycle/p53 pathways (luan2022deficiencyofribosomal pages 10-11, luan2022deficiencyofribosomal pages 1-2) | 60S vs 40S: more DTGs after 60S RP deficiency (t test, P = 0.018); greater p53 protein increase for Group 1 RPs (P = 4.2e−07); more elevated p53 target genes (P = 1.657e−15); enrichment for nucleus-entering RPs (hypergeometric P = 0.00034) (luan2022deficiencyofribosomal pages 10-11) | Indirect but relevant evidence for likely pathway context of RPL18A as a 60S RP involved in nuclear ribosome biogenesis and ribosomal-stress/p53 responses (luan2022deficiencyofribosomal pages 10-11, luan2022deficiencyofribosomal pages 1-2) |
| 2023 | Zhang, Cell | May 25, 2023 | https://doi.org/10.1016/j.cell.2023.04.026 | K562 and HEK293T cells mentioned in extracted methods/discussion | Cysteine-focused chemical proteomics plus functional genomics to identify anticancer drug targets and ROS-sensitive proteins | RPL18A contained a ROS-controlled cysteine site (C22) identified among sites for ROS-controlled translation in the study’s integrated proteogenomic framework (as summarized in retrieved evidence) (zhang2023systematicidentificationof pages 18-19, zhang2023systematicidentificationof pages 1-3, zhang2023systematicidentificationof pages 11-13) | Specific residue reported: C22 in RPL18A; no effect size for RPL18A itself in extracted snippet (zhang2023systematicidentificationof pages 18-19) | Recent evidence linking RPL18A to redox-sensitive translational regulation at the residue level; suggests possible post-translational modulation rather than changing its core ribosomal identity (zhang2023systematicidentificationof pages 18-19, zhang2023systematicidentificationof pages 1-3, zhang2023systematicidentificationof pages 11-13) |
| 2024 | Lindahl, International Journal of Molecular Sciences | Oct 17, 2024 | https://doi.org/10.3390/ijms252011186 | General eukaryotic ribosome biology | Perspective/review on ribosome heterogeneity and ribosome assembly | The review states that in eukaryotes ribosome assembly begins in the nucleolus, continues in the nucleoplasm, and is completed after export to the cytoplasm (lindahl2024ribosomestructuralchanges pages 1-2) | No RPL18A-specific quantitative detail in snippet (lindahl2024ribosomestructuralchanges pages 1-2) | Indirect localization/biogenesis context for all cytoplasmic RPs including RPL18A: nucleolus → nucleoplasm → cytoplasm maturation pathway (lindahl2024ribosomestructuralchanges pages 1-2) |
| 2025 | Kim, Scientific Reports | Jul 2025 | https://doi.org/10.1038/s41598-025-10316-3 | Caenorhabditis elegans rpl-20, ortholog of mammalian RPL18a/eL20 | Genetics plus ribosome profiling in an orthologous animal model | rpl-20/RPL18a-eL20 is a 60S large-subunit component; a conserved missense mutation reduced 60S biogenesis and 80S ribosomes, caused slow growth, and a full deletion was early larval lethal (kim2025ribosomalproteinmutation pages 1-2) | Conserved Gly82→Arg in worm (Gly79 in mammals); 60S amount “markedly reduced”; full deletion caused homozygous early larval lethality; suppression stronger as homozygote than heterozygote (kim2025ribosomalproteinmutation pages 1-2) | Strong orthology-based support that eL20 is essential for 60S biogenesis and organismal viability; useful when direct human mechanistic studies are sparse (kim2025ribosomalproteinmutation pages 1-2) |
Table: This table compiles the most relevant retrieved sources that explicitly mention RPL18A/eL20 or provide closely related functional context. It helps distinguish direct evidence on RPL18A from broader ribosomal-protein background relevant to annotating its role in translation, ribosome biogenesis, localization, and stress-related pathways.
RPL18A as an essential 60S component: Orthology evidence showing loss-of-function lethality and reduced 60S/80S abundance with an eL20-family mutation strongly supports that RPL18A’s primary biological role is canonical ribosome function—supporting 60S biogenesis and translation capacity. (kim2025ribosomalproteinmutation pages 1-2)
Ribosome specialization framework: Recent reviews argue that ribosomes can vary in composition and modification, and such variation may produce selective translation of subsets of mRNAs (specialized ribosomes). This provides a plausible conceptual basis for investigating whether RPL18A abundance or modification (e.g., redox-sensitive cysteines) contributes to transcript-selective translation in particular tissues or disease states, though direct RPL18A-specific specialization evidence was not retrieved here. (miller2023specializedribosomesin pages 1-3, lindahl2024ribosomestructuralchanges pages 1-2)
Ribosomal stress/p53 coupling: Systematic perturbation of ribosomal proteins demonstrates strong coupling of 60S RP disruption to p53 signaling and growth inhibition, supporting the expectation that RPL18A perturbation in human cells—if sufficiently disruptive—could feed into p53-mediated stress programs. (luan2022deficiencyofribosomal pages 10-11, luan2022deficiencyofribosomal pages 1-2)
References
(kim2025ribosomalproteinmutation pages 1-2): Hon-Song Kim, Kaito Mitsuzumi, Shohei Kondo, Rie Yamaoka, Shinji Ihara, Hiroshi Otsuka, Chizu Yoshikata, Yukihiko Kubota, Takumi Tomohiro, Toshinobu Fujiwara, Kenji Kimura, Fumio Motegi, Yukimasa Shibata, Mikiko Takahashi, and Kiyoji Nishiwaki. Ribosomal protein mutation suppresses gonadal leader cell migration defects in mig-17/adamts mutants in caenorhabditis elegans. Scientific Reports, Jul 2025. URL: https://doi.org/10.1038/s41598-025-10316-3, doi:10.1038/s41598-025-10316-3. This article has 0 citations and is from a peer-reviewed journal.
(lindahl2024ribosomestructuralchanges pages 1-2): Lasse Lindahl. Ribosome structural changes dynamically affect ribosome function. International Journal of Molecular Sciences, 25:11186, Oct 2024. URL: https://doi.org/10.3390/ijms252011186, doi:10.3390/ijms252011186. This article has 13 citations.
(luan2022deficiencyofribosomal pages 1-2): Yizhao Luan, Nan Tang, Jiaqi Yang, Shuting Liu, Chichi Cheng, Yan Wang, Congying Chen, Ya-nan Guo, Hongwei Wang, Wenxue Zhao, Qian Zhao, Wei Li, Mengqing Xiang, Rong Ju, and Zhi Xie. Deficiency of ribosomal proteins reshapes the transcriptional and translational landscape in human cells. Nucleic Acids Research, 50:6601-6617, Feb 2022. URL: https://doi.org/10.1093/nar/gkac053, doi:10.1093/nar/gkac053. This article has 95 citations and is from a highest quality peer-reviewed journal.
(luan2022deficiencyofribosomal pages 10-11): Yizhao Luan, Nan Tang, Jiaqi Yang, Shuting Liu, Chichi Cheng, Yan Wang, Congying Chen, Ya-nan Guo, Hongwei Wang, Wenxue Zhao, Qian Zhao, Wei Li, Mengqing Xiang, Rong Ju, and Zhi Xie. Deficiency of ribosomal proteins reshapes the transcriptional and translational landscape in human cells. Nucleic Acids Research, 50:6601-6617, Feb 2022. URL: https://doi.org/10.1093/nar/gkac053, doi:10.1093/nar/gkac053. This article has 95 citations and is from a highest quality peer-reviewed journal.
(miller2021fatalattractionthe pages 8-9): Clare M. Miller, Sangeetha Selvam, and Gabriele Fuchs. Fatal attraction: the roles of ribosomal proteins in the viral life cycle. Wiley Interdisciplinary Reviews: RNA, Jul 2021. URL: https://doi.org/10.1002/wrna.1613, doi:10.1002/wrna.1613. This article has 42 citations.
(zhang2023systematicidentificationof pages 18-19): Junbing Zhang, Claire M. Simpson, Jacqueline Berner, Harrison B. Chong, Jiafeng Fang, Zehra Ordulu, Tommy Weiss-Sadan, Anthony P. Possemato, Stefan Harry, Mariko Takahashi, Tzu-yi Yang, Marianne Richter, Himani Patel, Abby E. Smith, Alexander D. Carlin, Adriaan F. Hubertus de Groot, Konstantin Wolf, Lei Shi, Ting-Yu Wei, Benedikt R. Dürr, Nicholas J. Chen, Tristan Vornbäumen, Nina O. Wichmann, Mohammed S. Mahamdeh, Venkatesh Pooladanda, Yusuke Matoba, Shaan Kumar, Eugene Kim, Sara Bouberhan, Esther Oliva, Bo R. Rueda, Roy J. Soberman, Nabeel Bardeesy, Brian B. Liau, Michael Lawrence, Matt P. Stokes, Sean A. Beausoleil, and Liron Bar-Peled. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ros-sensing pathway. Cell, 186:2361-2379.e25, May 2023. URL: https://doi.org/10.1016/j.cell.2023.04.026, doi:10.1016/j.cell.2023.04.026. This article has 144 citations and is from a highest quality peer-reviewed journal.
(zhang2023systematicidentificationof pages 1-3): Junbing Zhang, Claire M. Simpson, Jacqueline Berner, Harrison B. Chong, Jiafeng Fang, Zehra Ordulu, Tommy Weiss-Sadan, Anthony P. Possemato, Stefan Harry, Mariko Takahashi, Tzu-yi Yang, Marianne Richter, Himani Patel, Abby E. Smith, Alexander D. Carlin, Adriaan F. Hubertus de Groot, Konstantin Wolf, Lei Shi, Ting-Yu Wei, Benedikt R. Dürr, Nicholas J. Chen, Tristan Vornbäumen, Nina O. Wichmann, Mohammed S. Mahamdeh, Venkatesh Pooladanda, Yusuke Matoba, Shaan Kumar, Eugene Kim, Sara Bouberhan, Esther Oliva, Bo R. Rueda, Roy J. Soberman, Nabeel Bardeesy, Brian B. Liau, Michael Lawrence, Matt P. Stokes, Sean A. Beausoleil, and Liron Bar-Peled. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ros-sensing pathway. Cell, 186:2361-2379.e25, May 2023. URL: https://doi.org/10.1016/j.cell.2023.04.026, doi:10.1016/j.cell.2023.04.026. This article has 144 citations and is from a highest quality peer-reviewed journal.
(zhang2023systematicidentificationof pages 11-13): Junbing Zhang, Claire M. Simpson, Jacqueline Berner, Harrison B. Chong, Jiafeng Fang, Zehra Ordulu, Tommy Weiss-Sadan, Anthony P. Possemato, Stefan Harry, Mariko Takahashi, Tzu-yi Yang, Marianne Richter, Himani Patel, Abby E. Smith, Alexander D. Carlin, Adriaan F. Hubertus de Groot, Konstantin Wolf, Lei Shi, Ting-Yu Wei, Benedikt R. Dürr, Nicholas J. Chen, Tristan Vornbäumen, Nina O. Wichmann, Mohammed S. Mahamdeh, Venkatesh Pooladanda, Yusuke Matoba, Shaan Kumar, Eugene Kim, Sara Bouberhan, Esther Oliva, Bo R. Rueda, Roy J. Soberman, Nabeel Bardeesy, Brian B. Liau, Michael Lawrence, Matt P. Stokes, Sean A. Beausoleil, and Liron Bar-Peled. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ros-sensing pathway. Cell, 186:2361-2379.e25, May 2023. URL: https://doi.org/10.1016/j.cell.2023.04.026, doi:10.1016/j.cell.2023.04.026. This article has 144 citations and is from a highest quality peer-reviewed journal.
(miller2023specializedribosomesin pages 1-3): Sarah C. Miller, Clinton C. MacDonald, Morgana K. Kellogg, Zemfira N. Karamysheva, and Andrey L. Karamyshev. Specialized ribosomes in health and disease. International Journal of Molecular Sciences, 24:6334, Mar 2023. URL: https://doi.org/10.3390/ijms24076334, doi:10.3390/ijms24076334. This article has 38 citations.
(hong2024researchprogressof pages 1-2): Yuqi Hong, Qisheng Lin, Yuan Zhang, Jilong Liu, and Zhanhong Zheng. Research progress of ribosomal proteins in reproductive development. International Journal of Molecular Sciences, 25:13151, Dec 2024. URL: https://doi.org/10.3390/ijms252313151, doi:10.3390/ijms252313151. This article has 12 citations.
(miller2021fatalattractionthe pages 9-11): Clare M. Miller, Sangeetha Selvam, and Gabriele Fuchs. Fatal attraction: the roles of ribosomal proteins in the viral life cycle. Wiley Interdisciplinary Reviews: RNA, Jul 2021. URL: https://doi.org/10.1002/wrna.1613, doi:10.1002/wrna.1613. This article has 42 citations.